PHVS — Pharvaris NV Balance Sheet
0.000.00%
Last trade - 00:00
- $1.26bn
- $837.12m
- 49
- 28
- 75
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 20.3 | 98.6 | 209 | 162 | 391 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.211 | 0.57 | 0.7 | 0.382 | 1.04 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 20.6 | 101 | 212 | 167 | 398 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.013 | 0.049 | 0.351 | 0.626 | 0.456 |
Other Long Term Assets | |||||
Total Assets | 20.6 | 101 | 212 | 168 | 399 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.92 | 5.31 | 6.99 | 18.2 | 14.6 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.92 | 5.31 | 7.14 | 18.5 | 14.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18.7 | 95.8 | 205 | 149 | 384 |
Total Liabilities & Shareholders' Equity | 20.6 | 101 | 212 | 168 | 399 |
Total Common Shares Outstanding |